In this issue, we add a couple of names to our Watch list. Vale (VALE) is a Brazilian mining giant that’s poised to benefit from a strengthening global economy (and the resolution of an ongoing legal case). We also feature BeiGene (BGNE), a Chinese biotech company that has a strong pipeline of candidate cancer drugs that may drive future revenues if clinical results are positive.
